Geus, P.F.; Hehnen, F.; Krakowski, S.; Lücke, K.; Hoon, D.S.B.; Frost, N.; Kertzscher, U.; Wendt, G.
Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood. Cancers 2022, 14, 4753.
https://doi.org/10.3390/cancers14194753
AMA Style
Geus PF, Hehnen F, Krakowski S, Lücke K, Hoon DSB, Frost N, Kertzscher U, Wendt G.
Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood. Cancers. 2022; 14(19):4753.
https://doi.org/10.3390/cancers14194753
Chicago/Turabian Style
Geus, Paul Friedrich, Felix Hehnen, Sophia Krakowski, Klaus Lücke, Dave S. B. Hoon, Nikolaj Frost, Ulrich Kertzscher, and Gabi Wendt.
2022. "Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood" Cancers 14, no. 19: 4753.
https://doi.org/10.3390/cancers14194753
APA Style
Geus, P. F., Hehnen, F., Krakowski, S., Lücke, K., Hoon, D. S. B., Frost, N., Kertzscher, U., & Wendt, G.
(2022). Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood. Cancers, 14(19), 4753.
https://doi.org/10.3390/cancers14194753